Cargando…
Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy
Atorvastatin, which has been approved by regulatory agencies for primary- and secondary-prevention patients with dyslipidemia, has historically been the most commonly prescribed statin and is now widely available in generic formulations. Despite widespread statin usage, many patients fail to attain...
Autores principales: | Tsioufis, Konstantinos, Castellano Vázquez, José María, Sykara, Georgia, Mondello Malvestiti, Franco, van Vugt, Joris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555050/ https://www.ncbi.nlm.nih.gov/pubmed/34586613 http://dx.doi.org/10.1007/s40119-021-00240-8 |
Ejemplares similares
-
Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature
por: Tsioufis, Konstantinos, et al.
Publicado: (2020) -
Artificial Intelligence Solutions to Increase Medication Adherence in Patients With Non-communicable Diseases
por: Babel, Aditi, et al.
Publicado: (2021) -
Efficacy of Generic Atorvastatin in a Real-World Setting
por: Manasirisuk, Panisa, et al.
Publicado: (2021) -
Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence
por: Dupclay, Leon, et al.
Publicado: (2012) -
Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)